Clinical Trial 46729

North Las Vegas, NV 89030


Evaluate the Efficacy, Safety, and Tolerability of the drug in treating patients with Moderate to Severe Persistent Asthma with Type 2 Inflammation

  1. Be currently receiving treatment with medium to high dose inhaled corticosteroids (ICS) in combination with at least 1 additional reliever/controller for at least 90 days prior to the Screening Visit with a stable dose of ICS at least 28 days prior to the Screening Visit.
  2. Have experienced an asthma exacerbation at least once in the past 12 months.

Qualified Participants May Receive:

$100 Per completed in person visit.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.